STAMFORD, Conn., Nov. 22, 2016 /PRNewswire/ -- (Booth #6713, North Building, Hall B) –FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, will demonstrate the FDR D-EVO GL detector at the 2016 annual meeting of the Radiological Society of North America (RSNA), held November 27-December 2 at McCormick Place in Chicago, Illinois. Built to capture long-length digital images in a single exposure, the FDR D-EVO GL features Fujifilm's breakthrough Virtual Grid image processing. Depending on the exam type and patient, FDR D-EVO GL with Virtual Grid can produce images with contrast and clarity comparable to exams performed with a physical grid while requiring as little as half the dose. As of November, the FDR D-EVO GL is now shipping to customers nationwide.
"Fujifilm's FDR D-EVO GL detector with Virtual Grid allows technologists to efficiently acquire long-length exams with a single low dose DR exposure, generating high quality images without a grid with as much as 50% lower dose than grid exams1," said Rob Fabrizio, director of strategic marketing, Digital X-ray and Women's Health at FUJIFILM Medical Systems U.S.A., Inc. "The acquisition speed and dose savings particularly benefits routine patients in acute postoperative pain and pediatric scoliosis patients on whom these tests are performed recurrently."
FDR D-EVO GL features a 17 x 49" field of view; its wider format helps improve patient safety and lower dose with fewer repeats from anatomy cutoff. Compared to multiple exposure conventional long length DR imaging, GL's single exposure improves processes of care and simplifies exam time to improve patient experiences. Long length imaging has been one of the last holdout areas in transitioning to DR due to CR's single exposure acquisition; compared to CR the FDR D-EVO GL with Virtual Grid processing can lower dose and dramatically shorten time to acquire and display. Capture is instant and 34" – 49" images display in 18-24 sec., whereas with CR there is much added time for processing cassettes and imaging plates.
Virtual Grid image processing is a great complement to the FDR D-EVO GL and can be used for all body parts (except for breast imaging). In mobile imaging Virtual Grid gives technologists new flexibility to perform high-quality imaging while eliminating associated grid misalignment artifacts and retakes. It further simplifies positioning by eliminating heavy grid caps and making the detector more comfortable behind the patient. Virtual Grid automatically adapts processing to replicate physical grid use, enhancing image contrast. It also offers automated and selectable grid characteristics to further adapt to site preferences.
To register for a product demonstration at RSNA 2016 or to learn more about Fujifilm's comprehensive digital x-ray portfolio please visit: http://rsna.fujimed.com/.
1 Based on Fujifilm's performance testing and image quality evaluation results.
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women's health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujifilmhealthcare.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2016, the company had global revenues of $22.1 billion, at an exchange rate of 112.54 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.
For more information:
Last updated on: 24/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.